{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:24:24Z","timestamp":1793384664364,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier","isbn-type":[{"value":"9780443429835","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.irn.2025.04.028","type":"book-chapter","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T08:33:19Z","timestamp":1753259599000},"page":"161-196","source":"Crossref","is-referenced-by-count":20,"title":["Epidemiology of myasthenia gravis"],"prefix":"10.1016","member":"78","reference":[{"issue":"4","key":"10.1016\/bs.irn.2025.04.028_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.9834","article-title":"Outcomes of COVID-19 infection and vaccination among individuals with myasthenia gravis","volume":"6","author":"Alcantara","year":"2023","journal-title":"Jama Network Open"},{"key":"10.1016\/bs.irn.2025.04.028_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/ane.12233","article-title":"Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries","volume":"198","author":"Andersen","year":"2014","journal-title":"Acta Neurologica Scandinavica. Supplementum"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.028_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nrl.2014.09.007","article-title":"Prevalence of myasthenia gravis in the Catalan county of Osona","volume":"32","author":"Aragones","year":"2017","journal-title":"Neurologia"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.028_bib4","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/01.WNL.0000050461.05432.C5","article-title":"Myasthenia gravis:\u00a0A higher than expected incidence in the elderly","volume":"60","author":"Aragones","year":"2003","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.028_bib5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/mus.26132","article-title":"Survival and mortality of adult-onset myasthenia gravis in the population of Belgrade, Serbia","volume":"58","author":"Basta","year":"2018","journal-title":"Muscle & Nerve"},{"issue":"10","key":"10.1016\/bs.irn.2025.04.028_bib6","first-page":"959","article-title":"Incidence of seropositive myasthenia gravis in Cape Town and South Africa","volume":"97","author":"Bateman","year":"2007","journal-title":"South African Medical Journal = Suid-Afrikaanse Tydskrif vir Geneeskunde"},{"issue":"3-4","key":"10.1016\/bs.irn.2025.04.028_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000477733","article-title":"Incidence of autoimmune myasthenia gravis in a Health Maintenance Organization in Buenos Aires, Argentina","volume":"48","author":"Bettini","year":"2017","journal-title":"Neuroepidemiology"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.028_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/mus.25408","article-title":"Prevalence and clinical aspects of immigrants with myasthenia gravis in Northern Europe","volume":"55","author":"Boldingh","year":"2017","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.028_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nmd.2015.10.009","article-title":"Epidemiology of myasthenia gravis in Ontario, Canada","volume":"26","author":"Breiner","year":"2016","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.028_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000375463","article-title":"Canadian administrative health data can identify patients with myasthenia gravis","volume":"44","author":"Breiner","year":"2015","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.028_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.25122\/jml-2020-0145","article-title":"The epidemiology of myasthenia gravis","volume":"14","author":"Bubuioc","year":"2021","journal-title":"The Journal of Medicine and Life"},{"issue":"12","key":"10.1016\/bs.irn.2025.04.028_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261983","article-title":"Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data","volume":"16","author":"Carey","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2025.04.028_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.028_bib14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/ane.12967","article-title":"Clinical and epidemiological features of myasthenia gravis in Chilean population","volume":"138","author":"Cea","year":"2018","journal-title":"Acta Neurologica Scandinavica"},{"issue":"21-22","key":"10.1016\/bs.irn.2025.04.028_bib15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00508-012-0258-2","article-title":"Epidemiology of myasthenia gravis in Austria: Rising prevalence in an ageing society","volume":"124","author":"Cetin","year":"2012","journal-title":"Wiener Klinische Wochenschrift"},{"key":"10.1016\/bs.irn.2025.04.028_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanwpc.2020.100063","article-title":"Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study","volume":"5","author":"Chen","year":"2020","journal-title":"Lancet Regional Health-Western Pacific"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.028_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/08830738030180030201","article-title":"Prevalence of neuromuscular diseases in Chinese children: A study in southern China","volume":"18","author":"Chung","year":"2003","journal-title":"Journal of Child Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2025.04.028_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.33588\/rn.7607.2023067","article-title":"Prevalence of myasthenia gravis in Colombia","volume":"76","author":"Clavijo-Prado","year":"2023","journal-title":"Revue Neurologique"},{"issue":"8","key":"10.1016\/bs.irn.2025.04.028_bib19","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.4049\/jimmunol.175.8.5050","article-title":"Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses","volume":"175","author":"Delpy","year":"2005","journal-title":"Journal of Immunology"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.028_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16233","article-title":"The epidemiology and societal costs of myasthenia gravis in Norway: A non-interventional study using national registry data","volume":"31","author":"Engebretsen","year":"2024","journal-title":"European Journal of Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.028_bib21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/joim.12310","article-title":"The autoimmune spectrum of myasthenia gravis: A Swedish population-based study","volume":"277","author":"Fang","year":"2015","journal-title":"Journal of Internal Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.028_bib22","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10072-019-04146-1","article-title":"Hospital and healthcare insurance system record-based epidemiological study of myasthenia gravis in southern and northern China","volume":"41","author":"Fang","year":"2020","journal-title":"Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.028_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/003693300204700604","article-title":"A limited epidemiological study of seropositive myasthenia gravis in Tayside","volume":"47","author":"Farrugia","year":"2002","journal-title":"Scottish Medical Journal"},{"issue":"11-12","key":"10.1016\/bs.irn.2025.04.028_bib24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00508-015-0796-5","article-title":"Estimation of incidence, prevalence, and age-at-diagnosis of myasthenia gravis among adults by hospital discharge records","volume":"127","author":"Foldvari","year":"2015","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.028_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nrl.2020.06.011","article-title":"Epidemiology of myasthenia gravis in the province of Ourense (Galicia, Spain)","volume":"38","author":"Garcia Estevez","year":"2023","journal-title":"Neurologia (Engl Ed)"},{"issue":"11","key":"10.1016\/bs.irn.2025.04.028_bib26","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1468-1331.2012.03698.x","article-title":"A national epidemiological study of Myasthenia Gravis in Australia","volume":"19","author":"Gattellari","year":"2012","journal-title":"European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies"},{"key":"10.1016\/bs.irn.2025.04.028_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16229","article-title":"Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment","author":"Gilhus","year":"2024","journal-title":"European Journal of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.028_bib28","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00415-018-8751-9","article-title":"Myasthenia gravis and infectious disease","volume":"265","author":"Gilhus","year":"2018","journal-title":"Journal of Neurology"},{"key":"10.1016\/bs.irn.2025.04.028_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nature Reviews Disease Primers"},{"issue":"12","key":"10.1016\/bs.irn.2025.04.028_bib30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.nmd.2021.07.396","article-title":"Myasthenia gravis:\u00a0Do not forget the patient perspective","volume":"31","author":"Gilhus","year":"2021","journal-title":"Neuromuscular Disorders"},{"issue":"10","key":"10.1016\/bs.irn.2025.04.028_bib31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: Subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2025.04.028_bib32","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1007\/s00415-023-11733-y","article-title":"Myasthenia gravis, respiratory function, and respiratory tract disease","volume":"270","author":"Gilhus","year":"2023","journal-title":"Journal of Neurology"},{"issue":"26","key":"10.1016\/bs.irn.2025.04.028_bib33","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia Gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.028_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.028_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mus.24697","article-title":"Mortality in myasthenia gravis: A nationwide population-based follow-up study in Denmark","volume":"53","author":"Hansen","year":"2016","journal-title":"Muscle & Nerve"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.028_bib36","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/mus.23271","article-title":"Geographical distribution of a seropositive myasthenia gravis population","volume":"45","author":"Heldal","year":"2012","journal-title":"Muscle & Nerve"},{"key":"10.1016\/bs.irn.2025.04.028_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ajo.2019.04.017","article-title":"Incidence, epidemiology, and transformation of ocular myasthenia gravis: A population-based study","volume":"205","author":"Hendricks","year":"2019","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.028_bib38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ane.12270","article-title":"Myasthenia gravis incidence in a general North Atlantic isolated population","volume":"130","author":"Joensen","year":"2014","journal-title":"Acta Neurologica Scandinavica"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.028_bib39","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mus.20030","article-title":"Clinical evaluation and management of myasthenia gravis","volume":"29","author":"Keesey","year":"2004","journal-title":"Muscle & Nerve"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.028_bib40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurol.2024.02.392","article-title":"Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data","volume":"180","author":"Keovilayhong","year":"2024","journal-title":"Revue Neurologique"},{"key":"10.1016\/bs.irn.2025.04.028_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1374370","article-title":"Impact of COVID-19 pandemic on the incidence and severity of myasthenia gravis in Korea: Using National Health Insurance Service database","volume":"15","author":"Kim","year":"2024","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/bs.irn.2025.04.028_bib42","article-title":"Occurrence and severity of myasthenic crisis in an unselected Turkish cohort of patients with myasthenia gravis","volume":"14","author":"Kose","year":"2023","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.028_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000311012","article-title":"Nationwide population-based epidemiological study of myasthenia gravis in taiwan","volume":"35","author":"Lai","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/bs.irn.2025.04.028_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fneur.2020.596981","article-title":"Myasthenia gravis: Autoantibody Specificities and their role in MG management","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Frontiers in Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.028_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3349\/ymj.2016.57.2.419","article-title":"The Epidemiology of myasthenia gravis in Korea","volume":"57","author":"Lee","year":"2016","journal-title":"Yonsei Medical Journal"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.028_bib46","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/WNL.0000000000003504","article-title":"A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland","volume":"88","author":"Lefter","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.028_bib47","first-page":"54","article-title":"Epidemiology of myasthenia gravis in the Republic of Belarus","volume":"114","author":"Likhachev","year":"2014","journal-title":"Zhurnal Nevrologii"},{"issue":"11","key":"10.1016\/bs.irn.2025.04.028_bib48","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2025.04.028_bib49","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1016\/S0022-510X(09)70739-7","article-title":"The pilot epidemiological study of myasthenia gravis in Republic of Georgia","volume":"285","author":"Lobjanidze","year":"2009","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/bs.irn.2025.04.028_bib50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fendo.2017.00169","article-title":"Autoimmune thyroiditis and myasthenia gravis","volume":"8","author":"Lopomo","year":"2017","journal-title":"Frontiers in Endocrinology\u00a0(Lausanne)"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.028_bib51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/ane.13239","article-title":"Incidence of AChR Ab-positive myasthenia gravis in Israel: A population-based study","volume":"142","author":"Lotan","year":"2020","journal-title":"Acta Neurologica Scandinavica"},{"issue":"10159","key":"10.1016\/bs.irn.2025.04.028_bib52","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/S0140-6736(18)32281-5","article-title":"Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: A systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Lozano","year":"2018","journal-title":"Lancet"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.028_bib53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000500268","article-title":"A prospective study of the incidence of myasthenia gravis in the East Midlands of England","volume":"53","author":"Maddison","year":"2019","journal-title":"Neuroepidemiology"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.028_bib54","article-title":"Clinical characteristics and treatment of Juvenile myasthenia gravis-a single-center experience","volume":"11","author":"Maeda","year":"2024","journal-title":"Children-Basel"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.028_bib55","doi-asserted-by":"crossref","first-page":"510","DOI":"10.7727\/wimj.2012.105","article-title":"Myasthenia gravis in South Trinidad","volume":"62","author":"Maharaj","year":"2013","journal-title":"The West Indian Medical Journal"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.028_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16022","article-title":"Clinical characteristics and treatment outcomes in patients with double-seronegative myasthenia gravis","volume":"31","author":"Martinez-Harms","year":"2024","journal-title":"European Journal of Neurology"},{"issue":"3-4","key":"10.1016\/bs.irn.2025.04.028_bib57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000487886","article-title":"Epidemiology of myasthenia gravis in Slovakia in the years 1977-2015","volume":"50","author":"Martinka","year":"2018","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.028_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00281-021-00842-3","article-title":"Thymus and autoimmunity","volume":"43","author":"Marx","year":"2021","journal-title":"Seminars in\u00a0Immunopathology"},{"issue":"9","key":"10.1016\/bs.irn.2025.04.028_bib59","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4314\/eamj.v78i9.8978","article-title":"Incidence and characteristics of Myasthenia gravis in Dar Es Salaam, Tanzania","volume":"78","author":"Matuja","year":"2001","journal-title":"East African Medical Journal"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.028_bib60","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-024-03553-y","article-title":"Systematic review of the patient burden of generalised myasthenia gravis in Europe, the Middle East, and Africa","volume":"24","author":"McCallion","year":"2024","journal-title":"BMC Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.028_bib61","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nmd.2023.02.002","article-title":"Epidemiology and treatment of myasthenia gravis: A retrospective study using a large insurance claims dataset in Germany","volume":"33","author":"Mevius","year":"2023","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"9","key":"10.1016\/bs.irn.2025.04.028_bib62","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.2009.177816","article-title":"Molecular characterisation of congenital myasthenic syndromes in Southern Brazil","volume":"81","author":"Mihaylova","year":"2010","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.028_bib63","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/mus.24348","article-title":"Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa","volume":"51","author":"Mombaur","year":"2015","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.028_bib64","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000336002","article-title":"Epidemiology and geographical variation of myasthenia gravis in the province of Pavia, Italy","volume":"38","author":"Montomoli","year":"2012","journal-title":"Neuroepidemiology"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.028_bib65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2011.03.004","article-title":"Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey","volume":"305","author":"Murai","year":"2011","journal-title":"Journal of the Neurological Sciences"},{"issue":"10258","key":"10.1016\/bs.irn.2025.04.028_bib66","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Murray","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.028_bib67","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3109\/08916934.2015.1030614","article-title":"Complicating autoimmune diseases in myasthenia gravis: a review","volume":"48","author":"Nacu","year":"2015","journal-title":"Autoimmunity"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.028_bib68","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1210\/en.2004-1003","article-title":"Differential estrogen receptor expression in autoimmune myasthenia gravis","volume":"146","author":"Nancy","year":"2005","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/bs.irn.2025.04.028_bib69","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.nmd.2017.08.003","article-title":"Molecular characterization of congenital myasthenic syndromes in Spain","volume":"27","author":"Natera-de Benito","year":"2017","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.028_bib70","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/jnnp.2006.102517","article-title":"Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands","volume":"78","author":"Niks","year":"2007","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2025.04.028_bib71","first-page":"11","article-title":"Management of Juvenile myasthenia gravis","author":"O\u2019Connell","year":"2020","journal-title":"Frontiers in Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.028_bib72","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/mus.21191","article-title":"Racial differences in myasthenia gravis in Alabama","volume":"39","author":"Oh","year":"2009","journal-title":"Muscle & Nerve"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.028_bib73","first-page":"497","article-title":"Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients","volume":"38","author":"Osserman","year":"1971","journal-title":"The Mount Sinai Journal of Medicine, New York"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.028_bib74","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jnnp.2005.072355","article-title":"Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001","volume":"77","author":"Owe","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.028_bib75","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000328863","article-title":"Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years","volume":"36","author":"Pallaver","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/bs.irn.2025.04.028_bib76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13690-018-0283-3","article-title":"Cardiovascular diseases monitoring: lessons from population-based registries to address future opportunities and challenges in Europe","volume":"76","author":"Palmieri","year":"2018","journal-title":"Arch Public Health"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.028_bib77","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/ane.13596","article-title":"Epidemiological profile of myasthenia gravis in South Korea using the national health insurance database","volume":"145","author":"Park","year":"2022","journal-title":"Acta Neurologica Scandinavica"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.028_bib78","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3988\/jcn.2016.12.3.340","article-title":"Incidence and prevalence of myasthenia gravis in Korea: A population-based study using the National Health Insurance Claims Database","volume":"12","author":"Park","year":"2016","journal-title":"J Clin Neurol"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.028_bib79","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/archdischild-2013-304788","article-title":"How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia","volume":"99","author":"Parr","year":"2014","journal-title":"Archives of Disease in Childhood"},{"issue":"10","key":"10.1016\/bs.irn.2025.04.028_bib80","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/WNL.42.10.1888","article-title":"The epidemiology of myasthenia gravis in central and western Virginia","volume":"42","author":"Phillips","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2025.04.028_bib81","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1196\/annals.1254.053","article-title":"The epidemiology of myasthenia gravis","volume":"998","author":"Phillips","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.028_bib82","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejpn.2016.09.001","article-title":"Juvenile myasthenia gravis in Norway: A nationwide epidemiological study","volume":"21","author":"Popperud","year":"2017","journal-title":"European Journal of Paediatric Neurology: EJPN: Official Journal of the European Paediatric Neurology Society"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.028_bib83","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jnnp.71.3.352","article-title":"Epidemiology of seropositive myasthenia gravis in Greece","volume":"71","author":"Poulas","year":"2001","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.028_bib84","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000110150","article-title":"Descriptive epidemiology of some rare neurological diseases in Benghazi, Libya","volume":"7","author":"Radhakrishnan","year":"1988","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.028_bib85","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1007\/s00415-021-10774-5","article-title":"Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019","volume":"269","author":"Raggi","year":"2022","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.028_bib86","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/mus.28006","article-title":"Incidence and prevalence of myasthenia gravis in the United States: A claims-based analysis","volume":"69","author":"Rodrigues","year":"2024","journal-title":"Muscle & Nerve"},{"key":"10.1016\/bs.irn.2025.04.028_bib87","unstructured":"Romanova,\u00a0T.\u00a0V. Samara epidemiological research of myasthenia gravis. Saratov Journal of Medical Scientific Research,\u00a08(1),\u00a091\u201395."},{"key":"10.1016\/bs.irn.2025.04.028_bib88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coi.2017.07.006","article-title":"Pathophysiology and immunological profile of myasthenia gravis and its subgroups","volume":"49","author":"Romi","year":"2017","journal-title":"Current Opinion in Immunology"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.028_bib89","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neurol.2023.09.004","article-title":"Epidemiology of myasthenia gravis in France: A retrospective claims database study (STAMINA)","volume":"180","author":"Salort-Campana","year":"2024","journal-title":"Revue Neurologique"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.028_bib90","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/mus.25068","article-title":"Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases","volume":"54","author":"Santos","year":"2016","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.028_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032487","article-title":"Population based study of 12 autoimmune diseases in Sardinia, Italy: Prevalence and comorbidity","volume":"7","author":"Sardu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2025.04.028_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000539577","article-title":"Prevalence, incidence, and mortality of myasthenia gravis and myasthenic syndromes: A systematic review","author":"Sciancalepore","year":"2024","journal-title":"Neuroepidemiology"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.028_bib93","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/mus.28077","article-title":"Epidemiology of seropositive myasthenia gravis in Sardinia: A population-based study in the district of Sassari","volume":"69","author":"Sechi","year":"2024","journal-title":"Muscle & Nerve"},{"key":"10.1016\/bs.irn.2025.04.028_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1214041","article-title":"Diagnosis and therapy of myasthenia gravis-the patients\u2019 perspective: A cross-sectional study","volume":"14","author":"Sobierajski","year":"2023","journal-title":"Frontiers in Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2025.04.028_bib95","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archneur.1991.00530190081019","article-title":"Epidemiology of myasthenia-gravis in Denmark - a longitudinal and comprehensive population survey","volume":"48","author":"Somnier","year":"1991","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.028_bib96","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/01.wnl.0000176067.32186.a3","article-title":"Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis","volume":"65","author":"Somnier","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2025.04.028_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/mus.28215","article-title":"Possible sex and racial disparities in myasthenia gravis care","author":"Suresh","year":"2024","journal-title":"Muscle & Nerve"},{"key":"10.1016\/bs.irn.2025.04.028_bib98","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejpn.2020.02.002","article-title":"Prevalence and genetic subtypes of congenital myasthenic syndromes in the pediatric population of Slovenia","volume":"26","author":"Troha Gergeli","year":"2020","journal-title":"European Journal of Paediatric Neurology: EJPN: Official Journal of the European Paediatric Neurology Society"},{"issue":"8","key":"10.1016\/bs.irn.2025.04.028_bib99","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1468-1331.2009.02624.x","article-title":"Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece","volume":"16","author":"Tsiamalos","year":"2009","journal-title":"European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.028_bib100","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/mus.27369","article-title":"Clinical profile and impact of comorbidities in patients with very-late-onset myasthenia gravis","volume":"64","author":"Vijayan","year":"2021","journal-title":"Muscle & Nerve"},{"issue":"8","key":"10.1016\/bs.irn.2025.04.028_bib101","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/jnnp.74.8.1105","article-title":"Evidence of underdiagnosis of myasthenia gravis in older people","volume":"74","author":"Vincent","year":"2003","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2025.04.028_bib102","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2023-333097","article-title":"Epidemiology of myasthenia gravis in Denmark, Finland and Sweden: A population-based observational study","author":"Vissing","year":"2024","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.028_bib103","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000529583","article-title":"Incidence, prevalence, hospitalization rates, and treatment patterns in myasthenia gravis: A 10-Year real-world data analysis of german claims data","volume":"57","author":"Wartmann","year":"2023","journal-title":"Neuroepidemiology"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.028_bib104","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/ane.13017","article-title":"Lifestyle factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis","volume":"138","author":"Westerberg","year":"2018","journal-title":"Acta Neurologica Scandinavica"},{"issue":"11","key":"10.1016\/bs.irn.2025.04.028_bib105","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1819","article-title":"Epidemiology of Myasthenia Gravis in Sweden 2006-2016","volume":"10","author":"Westerberg","year":"2020","journal-title":"Brain Behav"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.028_bib106","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ene.13535","article-title":"A nationwide epidemiological study of myasthenia gravis in Latvia","volume":"25","author":"Zieda","year":"2018","journal-title":"European Journal of Neurology: the Official Journal of the European Federation of Neurological Societies"}],"container-title":["International Review of Neurobiology","Myasthenia Gravis: Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T09:44:05Z","timestamp":1753263845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774225000431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443429835"],"references-count":106,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2025.04.028","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}